Psychedelic drugs should be reclassified to encourage new research into their medical applications, a researcher argues in an opinion piece published in The British Medical Journal today. Before substances such as LSD were stigmatized during the "war on drugs" in the 1970s, studies suggested they could be useful in dealing with psychiatric disorders, writes James Rucker, a psychiatrist at King’s College London. But a number of restrictions — some legal and some financial — have made studying potentially-helpful drugs far too difficult.
"Legal prohibition of some psychotropic substances continues to be a condition of UN membership," Rucker writes, "even though the original reasons for classifying them as such were largely fallacious."
I...
Would the medical research benefits of reclassifying LSD outweigh the risks?
Aucun commentaire:
Enregistrer un commentaire